Clinical Trials · NCT07497399
Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis
- Phase
- Phase 2
- Recruitment status
- Recruiting
- Sponsor
- Johns Hopkins University
- Enrollment
- 120
- Start date
- Apr 2026
- Locations
- 2 sites, United States
- Primary endpoint
- Change in normalized (for head size) brain parenchymal volume (nBPV)